Abstract
There are three different types of restrictive surgical procedures for morbid obesity: vertical banded gastroplasty (VBG), adjustable gastric banding (AGB), and sleeve gastrectomy (SG). These procedures are currently realized via laparoscopy. The mechanism of VBG is related to the size of the gastric pouch and to the calibrated outlet. After a solid meal, patients describe a sensation of fullness and satiety or even epigastric or low-retrosternal discomfort, indicating pouch fullness; at this point the patient must stop eating. If eating continues, discomfort increases until voluntary or spontaneous regurgitation of the excess food occurs. Satiety is dependent on the thickness and consistency of the food eaten; hence patients who consume mainly liquids usually have less weight loss. Gastric motility may play a part in the rate of drainage of the gastric pouch, and excessive motility may be responsible for poor weight loss in some cases. The variability in weight loss after gastroplasty and other restrictive procedures highlights the fact that the final amount of weight loss depends on patient-controlled factors as well as on the surgical procedure. Following placement of laparoscopic AGB (LAGB), as soon as the patient ingests two spoonfuls the small gastric compartment above the band is filled and he or she experiences a feeling of fullness. Since it takes a long time for this compartment to empty because of the narrowed stoma, more food can be ingested only after substantial time has elapsed. The patient must therefore eat at a much slower pace, and this slower pace allows the satiety center to be stimulated. As the hunger sensation is no longer present, overall food intake is reduced. The major advantage of LAGB is the possibility to adjust the size of the outlet. Another hypothesis not confirmed as the mode of action of gastric banding was gut hormone modulation. The mechanism of action of laparoscopic SG (LSG) is not only the restriction obtained by resecting part of the body and the entire fundus of the stomach, leaving a small gastric tube of 100–150 ml. Hormonal changes following this procedure must also be considered. Ghrelin is a 28-amino-acid orexigenic peptide, secreted essentially by the fundus of the stomach, which stimulates feeding behavior and hunger. In LSG, the gastric fundus is resected and plasma ghrelin levels are expected to decrease following surgery. Another mechanism explaining weight loss after LSG could be the relationship between appetite and gastric emptying, as the gastric clearance seems to be improved.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Mason EE, Ito C (1967) Gastric bypass in obesity. Surg Clin North Am 47:1345–1351
Printen KJ, Mason EE (1973) Gastric surgery for relief of morbid obesity. Arch Surg 106:428–431
Gomez CA (1979) Gastroplasty in morbid obesity. Surg Clin North Am 59:1113–1120
Mason EE (1982) Vertical banded gastroplasty. Arch Surg 117:701–706
Mason EE (2003) Development and future of gastroplasties for morbid obesity. Arch Surg 138:361–366
Laws HL, Piatadosi S (1981) Superior gastric reduction procedure for morbid obesity: a prospective, randomized trial. Am J Surg 193:334–336
Chua TY, Mendiola RM (1995) Laparoscopic vertical banded gastroplasty. Obes Surg 5:77–80
Morino M, Toppino M, Bonnet G, Rosa R, Garrone C Laparoscopic vertical banded gastroplasty for morbid obesity. Assessment of efficacy. Surg Endosc 2002 16:1566–1572
Wang W, Yu PJ, Lee YC, Wei PL, Lee WJ (2005) Laparoscopic vertical banded gastroplasty: 5-year results. Obes Surg 15:1299–1303
Wilkinson LH, Peloso OA (1981) Gastric (reservoir) reduction for morbid obesity. Arch Surg 116:602–605
Kolle K (1982) Gastric banding (abstract). OMGI 7th Congress, Stockholm, 37:145
Molina, K, Oria HE (1983) Gastric segmentation: a new safe, effective, simple, readily revised and fully reversible surgical procedure for the correction of morbid obesity (abstract). 6th Bariatric Surgery Colloquium, Iowa City, June 2–3
Buchwald H (2002) Overview of bariatric surgery. J Am Coll Surg 194:367–375
Vassallo C, Andreoli M, La Manna A et al (2002) 60 reoperations on 890 patients after gastric restrictive surgery. Obes Surg 11:752–756
Kuzmak LI (1986) Silicone gastric banding: a simple and effective operation for morbid obesity. Contemp Surg 28:13–18
Forsell P, Hallberg D, Hellers G (1993) A gastric band with adjustable inner diameter for obesity surgery: preliminary studies. Obes Surg 3:303–306
Cadiere GB, Bruyns J, Himpens J, Favretti F (1994) Laparoscopic gastroplasty for morbid obesity. Br J Surg 81:1524
Bioenterics (INAMED) (2001) LAP-BAND Adjustable Gastric Banding System, US approved labeling, June 13
Schindler K, Prager G, Ballaban T et al (2004) Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest 34:549–554
Uzzan B, Catheline JM, Lagorce C et al (2007) Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patients. Obes Surg 17:1159–1164
Ram E, Vishne T, Diker D et al (2005) Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA-S levels. Obes Surg 15:1118–1123
Hanusch-Enserer U, Cauza E, Brabant G et al (2004) Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding. J Clin Endocrinol Metab 89:3352–3358
Kojima M, Hosoda H, Date Y et al (1999) Ghrelin is a growthhormone- releasing acylated peptide from stomach. Nature 402:656–660
Le Roux CW, Aylwin SJ, Batterham RL et al (2006) Gut hormone profiles following bariatric surgery favor an anoretic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243:108–114
Hess DS, Hess DW (1988) Biliopancreatic diversion with a duodenal switch. Obes Surg 8:267–282
Fried M (2008) The current science of gastric banding: an overview of pressure-volume theory in band adjustement. Surg Obes Relat Dis 4:S14-S21
Marceau P, Hould FS, Simard S et al (1998) Biliopancreatic diversion with duodenal switch. World J Surg 22:947–954
Johnston D, Dachtler J, Sue-Ling HM, King RF, Martin G (2003) The Magenstrasse and Mill operation for morbid obesity. Obes Surg 13:10–16
Silecchia GF, Boru C, Pecchia A et al (2006) Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg 16:1138–1144
Mognol P, Chosidow D, Marmuse JP (2005) Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg 15:1030–1033
Gagner M, Inabnet WB, Pomp A (2005) Laparoscopic sleeve gastrectomy with second stage biliopancreatic diversion and duodenal switch in the superobese. In: Inabnet WB, DeMaria EJ, Ikramuddin S (eds) Laparoscopic bariatric surgery. Lippincott William & Wilkins. Philadelphia pp 143–50
Almogy G, Crookes PF, Anthone GJ (2004) Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg 14:492–497
Baltasar A, Serra C, Perez N, Bou R, Bengochea M, Ferri L(2005) Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg 15:1124–1128
Cottam D, Qureshi FG, Mattar SG et al (2006) Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 20:859–863
Robinson J, Sue-Ling H, Johnston D (2006) The Magenstrasse and Mill procedure can be combined with a Roux-en-Y gastric bypass to produce greater and sustained weight loss. Obes Surg 16:891–896
Nguyen NT, Longoria M, Gelfand DV, Sabio A, Wilson SE (2005) Staged laparoscopic Roux-en-Y: a novel two-stage bariatric operation as an alternative in the super-obese with massively enlarged liver. Obes Surg 15:1077–1081
Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super super-obese patients. Obes Surg 13:861–864
Vidal J, Ibarzabal A, Nicolau J et al (2007) Short-term effects of sleeve gastrectomy on type-2 diabetes mellitus in severely obese subjects. Obes Surg 17:1069–1074
Fruhbeck G, Diez-Caballero A, Gil MJ et al (2004) The decrease in plasma ghrelin concentrations following bariatric surgery on the functional integrity of the fundus. Obes Surg 14:606–612
Langer FB, Reza Hoda MA, Bohdjalian A et al (2005) Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 15:1024–1029
Himpens J, Dapri G, Cadiere GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16:1450–1456
Cohen R, Uzzan B, Bihan H, Khochtali I, Reach G, Catheline JM (2005) Ghrelin levels and sleeve gastrectomy in super superobesity. Obes Surg 15:1501–1502
Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247:401–407
Bergmann JF, Chassany O, Petit A et al (1992) Correlation between echographic gastric emptying and appetite: influence of psyllium. Gut 33:1042–1043
Carmichael AR, Johnston D, Baker MC et al (2001) Gastric emptying after a new, more physiological anti-obesity operation: the Magenstrasse and Mill procedure. Eur J Nucl Med 28:1379–1383
Melissas J, Koukouraki S, Askoxylakis J et al (2007) Sleeve gastrectomy: a restrictive procedure? Obes Surg 17:57–62
Gagner M (2008) Sleeve gastrectomy provides resolution of type-2 diabetes without duodenal exclusion. The 2007 International Consensus Summit on Sleeve Gastrectomy. Bariatric Times. Clinical developments and metabolic insights in total bariatric patient care. June Supplement A, pp 5–6
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dapri, G., Cadière, G.B., Himpens, J. (2012). Pathophysiology of Restrictive Procedures. In: Karcz, W.K., Thomusch, O. (eds) Principles of Metabolic Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02411-5_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-02411-5_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02410-8
Online ISBN: 978-3-642-02411-5
eBook Packages: MedicineMedicine (R0)